Search This Blog

Wednesday, April 26, 2023

Stoke Therapeutics resumed at Buy by Canaccord

 Target $24

https://finviz.com/quote.ashx?t=STOK&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.